Literature DB >> 11048435

High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine.

P Schreiber1, J P Matheise, F Dessy, M Heimann, J J Letesson, P Coppe, A Collard.   

Abstract

In a group of 60 Belgian White Blue calves less than 8 months old still housed in barns, a bovine respiratory syncytial virus (BRSV) outbreak was revealed on the basis of a direct diagnosis (immunofluorescence and virus isolation) performed on the lungs of dead animals, and the kinetics of BRSV neutralizing antibodies. Clinical signs, macroscopical and microscopical pulmonary lesions were also compatible with a BRSV infection. This outbreak is peculiar because the 35 oldest calves (204 +/- 29 days old) had been vaccinated 3-4 months before with an inactivated BRSV vaccine and 30% of these animals had died of respiratory distress. While they experienced a mild respiratory symptomatology, no death was recorded among the 25 youngest calves (69 +/- 29 days old) which had been left unvaccinated. Another peculiarity was found at the histological level where a massive infiltration of eosinophils was demonstrated in the pulmonary tissues of the dead animals. Together these data parallel the dramatic story described 30 years ago in children previously vaccinated with a formalin-inactivated human RSV (HRSV) vaccine upon a natural HRSV challenge. This illustrates that an immunopathological phenomenon also takes place after BRSV vaccination in cattle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11048435     DOI: 10.1046/j.1439-0450.2000.00380.x

Source DB:  PubMed          Journal:  J Vet Med B Infect Dis Vet Public Health        ISSN: 0931-1793


  26 in total

1.  Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.

Authors:  John A Ellis; Keith H West; Cheryl Waldner; Carrie Rhodes
Journal:  Can Vet J       Date:  2005-02       Impact factor: 1.008

Review 2.  Immune responses and disease enhancement during respiratory syncytial virus infection.

Authors:  Peter J M Openshaw; John S Tregoning
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 3.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.

Authors:  Mathieu Boxus; Marylène Tignon; Stefan Roels; Jean-François Toussaint; Karl Walravens; Marie-Ange Benoit; Philippe Coppe; Jean-Jacques Letesson; Carine Letellier; Pierre Kerkhofs
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

5.  Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes.

Authors:  Ruth M Gaddum; Roy S Cook; Julie M Furze; Shirley A Ellis; Geraldine Taylor
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

Review 6.  Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.

Authors:  Patricio L Acosta; Mauricio T Caballero; Fernando P Polack
Journal:  Clin Vaccine Immunol       Date:  2015-12-16

7.  Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis.

Authors:  Adriaan F G Antonis; Remco S Schrijver; Franz Daus; Paul J G M Steverink; Norbert Stockhofe; Evert J Hensen; Johannes P M Langedijk; Robbert G van der Most
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection.

Authors:  Stephan W Glasser; Teah L Witt; Albert P Senft; John E Baatz; Dusti Folger; Melissa D Maxfield; Henry T Akinbi; Danforth A Newton; Daniel R Prows; Thomas R Korfhagen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-20       Impact factor: 5.464

9.  A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Authors:  Fabián E Díaz; Mariana Guerra-Maupome; Paiton O McDonald; Daniela Rivera-Pérez; Alexis M Kalergis; Jodi L McGill
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

10.  A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody.

Authors:  Mirjam T W van der Sluijs; Eva M Kuhn; Birgit Makoschey
Journal:  BMC Vet Res       Date:  2010-01-11       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.